DARZALEX 1.800 MG SOLUCION INYECTABLE
DARZALEX 1.800 MG SOLUCION INYECTABLE
Commercialized
Register Number
1161101004IP
Prescription Type
Uso Hospitalario
Authorization Date
Feb 9, 2021
Dosage Form
SOLUCIÓN INYECTABLE
Route: VÍA SUBCUTÁNEA
Product Details
Detailed information about this CIMA AEMPS approved pharmaceutical product.
Basic Information
Key regulatory and product classification details
Regulatory Details
Register Number1161101004IP
EMA Approved
Yes
Drug Classification
✗
Generic
No
✓
Orphan
Yes
✗
Biosimilar
No
✓
Commercialized
Yes
CIMA AEMPS Classification
INGREDIENTS (1)
DARATUMUMABActive
Quantity: 1800 mg
Name: DARATUMUMAB
ATC CLASSIFICATION (3)
L01F
L01FC
L01FC01